Hemp-derived cannabidiol, aka CBD, is all the rage in holistic medicine. Products litter shelves of health stores and users swear that CBD helps combat several ailments like anxiety, pain, and insomnia.
But serious research into the product has yet to be completed, so the medical community has remained somewhat skeptical on CBD’s effectiveness. Compassionate Certification Centers is hoping to change that. CCC is a Pittsburgh-based company that specializes in cannabis-based medicine and has several medical marijuana facilities throughout the country.
CCC co-founder and Chief Medical Officer Dr. Bryan Doner has started the first clinical study researching CBD’s efficacy in treating irritable bowel syndrome (IBS). Doner was able to start his clinical research thanks to the 2018 U.S. Farm Bill, which federally legalized hemp. Both hemp and marijuana are cannabis plants, but hemp contains very low amounts